Literature DB >> 9284370

Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.

J M McNicholl1, D K Smith, S H Qari, T Hodge.   

Abstract

Since the late 1970s, 8.4 million people worldwide, including 1.7 million children, have died of AIDS, and an estimated 22 million people are infected with human immunodeficiency virus (HIV)(1). During 1995 and 1996, major clinical and laboratory discoveries regarding HIV pathogenesis provided new hope for the prevention and treatment of HIV infection. One major discovery was that members of the chemokine receptor family serve as cofactors for HIV entry into cells. We describe the role of allelic polymorphism in the gene coding for the CCR5 chemokine receptor with regard to susceptibility to and disease course of HIV infection. We also examine the effect of this discovery on medical and public health practices.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284370      PMCID: PMC2627644          DOI: 10.3201/eid0303.970302

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  57 in total

1.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

Authors:  A Trkola; T Dragic; J Arthos; J M Binley; W C Olson; G P Allaway; C Cheng-Mayer; J Robinson; P J Maddon; J P Moore
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

2.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

Authors:  L Wu; N P Gerard; R Wyatt; H Choe; C Parolin; N Ruffing; A Borsetti; A A Cardoso; E Desjardin; W Newman; C Gerard; J Sodroski
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

3.  Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.

Authors:  P Garred; J Eugen-Olsen; A K Iversen; T L Benfield; A Svejgaard; B Hofmann
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

Review 4.  Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research.

Authors:  M P D'Souza; V A Harden
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

5.  Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines.

Authors:  R E Atchison; J Gosling; F S Monteclaro; C Franci; L Digilio; I F Charo; M A Goldsmith
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

6.  Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.

Authors:  P Garred; H O Madsen; U Balslev; B Hofmann; C Pedersen; J Gerstoft; A Svejgaard
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

7.  The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; A Cara; R C Gallo; P Lusso
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

8.  Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive persons.

Authors:  B M Brinkman; I P Keet; F Miedema; C L Verweij; M R Klein
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

9.  Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

Authors:  G Simmons; D Wilkinson; J D Reeves; M T Dittmar; S Beddows; J Weber; G Carnegie; U Desselberger; P W Gray; R A Weiss; P R Clapham
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

10.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

View more
  23 in total

1.  Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

Authors:  H D Shin; C Winkler; J C Stephens; J Bream; H Young; J J Goedert; T R O'Brien; D Vlahov; S Buchbinder; J Giorgi; C Rinaldo; S Donfield; A Willoughby; S J O'Brien; M W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.

Authors:  A D Sullivan; J Wigginton; D Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.

Authors:  Timothy J Henrich; Nicolas R P Lewine; Sun-Hee Lee; Suhas S P Rao; Reem Berro; Roy M Gulick; John P Moore; Athe M N Tsibris; Daniel R Kuritzkes
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 5.  Greater risk for HIV infection of black men who have sex with men: a critical literature review.

Authors:  Gregorio A Millett; John L Peterson; Richard J Wolitski; Ron Stall
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

6.  Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome.

Authors:  Ghalib Alkhatib
Journal:  Stem Cells Dev       Date:  2009 Jan-Feb       Impact factor: 3.272

7.  Estimation of 2Nes from temporal allele frequency data.

Authors:  Jonathan P Bollback; Thomas L York; Rasmus Nielsen
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

8.  Identification of multiple cyclin subunits of human P-TEFb.

Authors:  J Peng; Y Zhu; J T Milton; D H Price
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

9.  Impact of CCR2 and SDF1 polymorphisms on disease progression in HIV-infected subjects in Thailand.

Authors:  Palanee Ammaranond; Sayompoo Sanguansitthianan; Poonlaph Phaengchomduan; Chanachai Sae-Lee; Sirimarn Mardkhumchan
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

10.  Polymorphisms of IL-6 174 G/C, IL-10 -592 C/A and risk of HIV/AIDS among North Indian population.

Authors:  Ranbir Chander Sobti; Nega Berhane; Salih Abdul Mahedi; Rupinder Kler; Seyed Ali Hosseini; Vijish Kuttiat; Ajay Wanchu
Journal:  Mol Cell Biochem       Date:  2010-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.